QRS Width > 150 ms Response Ratio Calculator
QRS Duration Assessment
Enter the patient's intrinsic QRS duration to view the corresponding MADIT-CRT subgroup evidence.
QRS ≥150 ms
In MADIT-CRT, the CRT-D group had a lower hazard of the primary endpoint than the ICD-only group in this prespecified QRS-duration subgroup.
About this assessment
The original tool assigned a response ratio of 1.64 for QRS duration greater than 150 ms. That number could not be verified as a response ratio from the cited MADIT-CRT primary publication and has therefore been replaced by the published subgroup hazard ratios.
MADIT-CRT compared cardiac resynchronization therapy with a defibrillator (CRT-D) against an implantable cardioverter-defibrillator (ICD) alone in selected patients with mild heart-failure symptoms, reduced left ventricular ejection fraction, and prolonged QRS duration.
Published subgroup results
| Baseline QRS duration | HR for primary endpoint | 95% CI |
|---|---|---|
| ≥150 ms | 0.48 | 0.37–0.64 |
| <150 ms | 1.06 | 0.74–1.52 |
The primary endpoint was death from any cause or a nonfatal heart-failure event. The subgroup estimates describe relative hazard in the trial population and should not be interpreted as absolute risk, a relative probability of response, or a guaranteed treatment effect for an individual patient.
Clinical considerations
- Confirm QRS duration and morphology on a suitable ECG; do not interpret duration in isolation.
- Consider guideline-based indications, particularly LVEF, symptoms despite guideline-directed medical therapy, rhythm, and LBBB versus non-LBBB morphology.
- Use shared clinical decision-making; this calculator is an educational aid and does not replace guideline assessment.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.